Medication info
Mupain Sustained-Release Tablets

Mupain Sustained-Release Tablets

Prescription medicationTabletOral
Ingredient · strength
Acetaminophen›325mg / 1 tabletTramadol Hydrochloride›75mg / 1 tablet
Manufacturer / importer
Daehan New Pham Co., Ltd.
Appearance
Pale yellow oblong sustained-release film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201506781 · Approved 2015.09.24 · Insurance code 669906400

Summary

Main use
Relief of moderate to severe acute and chronic pain
Who takes it
Adults
Adult dose
Adults: The dose should be adjusted according to the severity of the patient's pain and response to treatment. A dose of 1 tablet is recommended initially. Thereafter, allow an interval of at least 12 hours between doses and do not exceed 4 tablets per day. Do not use this medicine for longer than necessary. If long-term treatment is required because of the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should be continued. Nausea, vomiting, itching, constipation, dizziness, and drowsiness may occur during treatment; therefore, monitor the patient's response closely and adjust treatment as appropriate. Elderly patients: Use the usual adult dose. However, because oral administration of tramadol to elderly patients aged 75 years or older increased the elimination half-life of tramadol by 17%, administer this medicine at intervals of at least 12 hours. Patients with renal impairment: The safety and efficacy of this medicine in patients with renal impairment have not been established; therefore, its use is not recommended. Patients with hepatic impairment: The safety and efficacy of this medicine in patients with hepatic impairment have not been established; therefore, its use is not recommended.

Ingredients

Manufacturer
Daehan New Pham Co., Ltd.

Efficacy & effects

Relief of moderate to severe acute and chronic pain

  • Acute pain
  • chronic pain
View approved original text

This medication is used to relieve acute and chronic pain ranging from moderate to severe.

How to take

Adult dose

Adults: The dose should be adjusted according to the severity of the patient's pain and response to treatment. A dose of 1 tablet is recommended initially. Thereafter, allow an interval of at least 12 hours between doses and do not exceed 4 tablets per day. Do not use this medicine for longer than necessary. If long-term treatment is required because of the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should be continued. Nausea, vomiting, itching, constipation, dizziness, and drowsiness may occur during treatment; therefore, monitor the patient's response closely and adjust treatment as appropriate. Elderly patients: Use the usual adult dose. However, because oral administration of tramadol to elderly patients aged 75 years or older increased the elimination half-life of tramadol by 17%, administer this medicine at intervals of at least 12 hours. Patients with renal impairment: The safety and efficacy of this medicine in patients with renal impairment have not been established; therefore, its use is not recommended. Patients with hepatic impairment: The safety and efficacy of this medicine in patients with hepatic impairment have not been established; therefore, its use is not recommended.

Precautions

This medication may cause liver damage, so those who regularly consume more than 3 drinks per day must consult a doctor or pharmacist before taking this medication or other analgesics. This medication can rarely cause serious skin reactions; therefore, if a rash or allergy symptoms occur after taking it, immediately stop taking it and inform a healthcare professional. The tramadol component in this medication can increase the risk of seizures, so patients with a history of seizures or at high risk for seizures should exercise special caution when taking it. Taking tramadol with certain antidepressants or other central nervous system depressants may increase the risk of seizures and respiratory depression, so it is essential to strictly follow the doctor's instructions when combining these medications. This medication can rarely cause life-threatening anaphylactic reactions, so if any hypersensitivity symptoms occur, seek medical attention immediately. Patients with acute and severe bronchial asthma may be at risk of respiratory depression when administered this medication; therefore, it should only be used in facilities equipped for professional monitoring and cardiopulmonary resuscitation. When taken along with alcohol or benzodiazepine medications, this medication can cause sedation and respiratory depression, which can lead to coma in severe cases; hence, extreme caution is necessary when concomitantly administered with these substances. Patients with elevated intracranial pressure or head injuries should be cautious when using this medication, as respiratory depression could further increase brain pressure. The tramadol in this medication can cause mental and physical dependence; therefore, long-term use should be considered for dependency risk based on a doctor's guidance. Patients with impaired liver function must consult a doctor before taking this medication and should ensure the total daily dose does not exceed 4,000mg when taking it alongside other acetaminophen-containing products. There is an increased risk of respiratory depression in ultra-rapid metabolizers of CYP2D6, so these patients should consider dose adjustments or alternative medications. This medication should not be administered to children under 12 years of age or to children under 18 years of age who have undergone tonsillectomy or adenoidectomy. This medication may cause hyponatremia; therefore, especially elderly patients or those with risk factors should regularly check their serum sodium levels. In cases of overdose, severe respiratory depression and liver damage can occur, so do not exceed the recommended dose, and if an overdose is suspected, seek medical assistance immediately. Drowsiness or dizziness may occur while taking this medication, so caution is needed when driving or operating machinery during these activities. Women who are pregnant or breastfeeding should consult a doctor before taking this medication, and nursing mothers should either discontinue breastfeeding or closely monitor their baby's condition while taking this medication.

Side effects

Liver damage, acute generalized eruptive pustulosis, Stevens-Johnson syndrome, toxic epidermal necrolysis, seizures, anaphylactic reactions, respiratory depression, deep sedation, coma, weakness, fatigue, flushing, chest pain, stiffness, fainting, withdrawal symptoms, hypertension, worsening hypertension, hypotension, arrhythmia, palpitations, tachycardia, dizziness, headache, tremors, ataxia, convulsions, hypertonia, migraine, exacerbation of migraine, involuntary muscle contractions, paresthesia, confusion, vertigo, abdominal pain, constipation, diarrhea, dyspepsia, flatulence, dry mouth, nausea, vomiting, dysphagia, hematochezia, tongue swelling, loss of appetite, anxiety, delirium, euphoria, insomnia, nervous irritability, drowsiness, forgetfulness, depersonalization, depression, substance abuse, dependence, emotional instability, hallucinations, erectile dysfunction, nightmares, abnormal thoughts, anemia, dyspnea, proteinuria, urination disorders, oliguria, urinary retention, pruritus, rash, sweating, urticaria, abnormal liver function, weight loss, tinnitus, abnormal vision, chills, vascular dilation, orthostatic hypotension, bradycardia, collapse, myocardial ischemia, pulmonary edema, respiratory symptoms, bronchospasm, wheezing, angioedema, allergic reactions, anaphylaxis, Stevens-Johnson syndrome, changes in appetite, muscle weakness, respiratory depression, cognitive dysfunction, concentration difficulties, suicidal tendencies, hepatitis, liver failure, gastrointestinal bleeding, delirium, miosis, mydriasis, speech disorders, movement disorders, hypoglycemia, hyponatremia, syndrome of inappropriate antidiuretic hormone secretion, thrombocytopenia, agranulocytosis, hypoprothrombinemia, fatigued glutamic acidosis, nausea, urticaria, itching, headache, constipation, dyspepsia, cold sweat, reduced appetite, dizziness, drowsiness, thirst, dry mouth, excessive sweating, rash, urination disorders, abdominal pain, insomnia, leukoplakia, rhinitis, nasopharyngitis, limb pain, arthralgia, muscle cramps, muscle weakness, myalgia, blurred vision, conjunctivitis, decreased immune response, sensory disturbances, drowsiness, dysgeusia, involuntary muscle contractions, tremors, migraine, urination disorders, hematuria, dark urine, anuria, delayed urination, urinary incontinence, oliguria, dry mouth, abdominal pain, abdominal discomfort, abdominal distension, upper abdominal discomfort, upper abdominal pain, peptic ulcer, diarrhea, belching, thirst, chest discomfort, facial swelling, chills, fever, peripheral edema, weakness, pallor, blood pressure fluctuations, dyspnea, cough, rhinorrhea, urine red blood cell positive, blood pressure increase, palpitations, irregular menstruation, breast cancer, injury, weakness, fatigue, fever, edema, chest pain, stiffness, fainting, congestive heart failure, dizziness, confusion, exercise-induced dyspnea, bronchitis, urinary retention, frequency of urination, abnormal kidney function levels, palpitations, aortic stenosis, bleeding, cholesterol increase, hip pain, thigh pain, allergic rhinitis, nosebleed, abnormal vision, progression of bile duct cancer, foreign body sensation in the eye, progression of liver cancer, paralytic ileus, cholecystitis, hiccups, increased salivation, bleeding, nausea, dizziness, confusion, migraine, speech disorders, loss of consciousness, recurrence of myocardial infarction, hypotension, confusion, multiple organ failure, anaphylaxis, intentional overdose, heartburn, acute gastritis, cold, upper respiratory infection, systemic weakness, motion sickness, lethargy, memory disturbances, inadequate effect, facial flushing, withdrawal symptoms, urticaria, bronchial spasm, toxic skin necrosis, Stevens-Johnson syndrome, panic attack, severe anxiety, hallucinations, perceptual disturbances, tinnitus, abnormal central nervous system response, severe respiratory depression, QT prolongation, liver failure, renal tubular necrosis, hypoglycemia, coagulation disorders, insomnia, rigidity, pain, diarrhea, upper respiratory syndrome, excitement, nervous irritability, hyperactivity, opioid-induced hyperalgesia, adrenal insufficiency symptoms, severe abdominal pain, hypotension, extreme fatigue, reduced appetite, weight loss

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture; therefore, store it in a tightly sealed container. The storage temperature should be kept between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

Pale yellow oblong sustained-release film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.